Media Summary: Join RMMSC Medical Director Dr. Timothy Vollmer for an in-depth look at disease modifying therapies (DMTs) – the front line in ... On Tuesday, November 29th our faculty shared the newest research happening here at the CGD Center along with their expert ... Dr. Timothy Vollmer gives an overview of the RMMSC's core treatment philosophy.
Multiple Sclerosis Webinar A Deep - Detailed Analysis & Overview
Join RMMSC Medical Director Dr. Timothy Vollmer for an in-depth look at disease modifying therapies (DMTs) – the front line in ... On Tuesday, November 29th our faculty shared the newest research happening here at the CGD Center along with their expert ... Dr. Timothy Vollmer gives an overview of the RMMSC's core treatment philosophy. Greg Tranah, Executive Director of Precision Medicine at Sutter Health, and Megan Laurance, Senior Director of Data Services at ... Board Chair David W. Dodick, MD, FAAN hosted an informative discussion with Scientific Advisory Board Member Raymond Roos ... The FDA officially approved Ocrelizumab (brand name: Ocrevus) for use in
Associate Professor Yasmine Probst is IHMRI's leading researcher on the effects of nutrition on MS. Yasmine is living with MS ... Dr. Amanda Piquet's presentation focuses on the rapidly evolving field of Autoimmune Neurology. She defines antibody-mediated ... Meeting Description: Have you recently been diagnosed with
